AERIFY-1/2:两项Itepekimab在前吸烟者中进行的3期随机对照试验,患者患有中度至重度的COPD
Klaus F Rabe1,2,3, Fernando J Martinez4, Surya P Bhatt5
1LungenClinic Grosshansdorf, Airway Research Center North, Grosshansdorf, Germany.
互白素-33抑制剂Itepekimab在减少COPD前吸烟者的恶化方面表现有前途. 第三期试验AERIFY-1和AERIFY-2正在评估其在这个患者群体中的疗效和安全性.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 免疫学 免疫学 免疫学
- 临床试验 临床试验
背景情况:
- 介素-33 (IL-33) 涉及慢性阻塞性肺病 (COPD) 的发生.
- 一项第二阶段研究表明,抗IL-33抗体伊特佩基马布可以减少COPD恶化,并改善前吸烟者的肺功能.
研究的目的:
- 评估Itepekimab与安慰剂之间的疗效和安全性,用于中度至重度COPD的前吸烟者.
- 为了评估 itepekimab 在52周内对恶化率和肺功能的影响.
主要方法:
- AERIFY-1和AERIFY-2是第三期,随机,双盲,安慰剂对照试验.
- 参与者是前吸烟者 (40-85岁),患有慢性肺炎和慢性支气管炎,尽管接受了标准护理,但最近出现了恶化.
- 主要终点:中度或重度COPD恶化的年率.
主要成果:
- 该摘要不包含AERIFY-1和AERIFY-2试验的结果.
- 第二阶段的数据表明,在一小组前吸烟者中,Itepekimab的结果是积极的.
结论:
- 伊特佩基马布 (Itepekimab) 正在作为前吸烟者中适度至重度COPD的潜在治疗方法进行研究.
- 需要AERIFY-1和AERIFY-2的进一步结果来确认有效性和安全性.
更多相关视频
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
